Precision Biologics, Inc. and National Cancer Institute Collaborators Deliver Poster Presentation at the ASCO Annual Meeting June 5, 2022

Precision Biologics, Inc. and our collaborators at the NCI deliver a poster presentation at the ASCO Annual Meeting June 5, 2022, 8-11a CDT, Chicago, IL, entitled “Phase I clinical trial of NEO-201, an anti-tumor-associated CEACAM-5/6 monoclonal antibody in solid tumors” poster #187.